Dec 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including HCA Healthcare, Ncino and Progyny, on Monday.
HIGHLIGHTS
* HCA Healthcare Inc : JP Morgan raises target price to $380
from $379
* Ncino Inc : KBW raises target price to $49 from $41
* Progyny Inc : JP Morgan cuts to neutral from overweight
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
* Ardent Health Partners Inc : JP Morgan raises target price to
$20 from $19
* HCA Healthcare Inc : JP Morgan raises target price to $380 from
$379
* Ncino Inc : KBW raises target price to $49 from $41
* Progyny Inc : JP Morgan cuts target price to $17 from $22
* Progyny Inc : JP Morgan cuts to neutral from overweight
* Tenet Healthcare Corp : JP Morgan raises target price to $175
from $172
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。